Next 10 |
2024-04-18 11:00:03 ET Morten Herholdt from Johnson Rice issued a price target of $170.00 for JNJ on 2024-04-18 09:13:00. The adjusted price target was set to $170.00. At the time of the announcement, JNJ was trading at $145.08. The overall price target consensus is at $...
A look at the top 10 most actives in Canada Troilus Gold Corp (TLG) rose 1.4% to $0.7 on volume of 19,342,615 shares Royal Bank of Canada (RY) fell 0.1% to $133.2 on volume of 3,932,729 shares Desjardins RI Developed ex-USA ex-Canada - Low CO2 Index ETF (DRMD) rose 0.0% to $26.72 on volum...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 73.2% to $0.0646 on volume of 191,555,690 shares AGBA Group Holding Limited (AGBA) rose 245.0% to $1.38 on volume of 41,065,125 shares TIAN RUIXIANG Holdings Ltd (TIRX) rose 135.2% to $1.14 on volum...
2024-04-18 07:28:39 ET Summary On April 16, Johnson & Johnson released financial results for the first three months of 2024, which were within my expectations. Tecvayli sales were $133 million in the first quarter of 2024, up 111% year over year. Despite increased competit...
2024-04-17 17:30:03 ET Johnson Rice analyst issues OVERWEIGHT recommendation for JNJ on April 17, 2024 03:37PM ET. The previous analyst recommendation was Overweight. JNJ was trading at $144.77 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-04-17 16:35:54 ET More on Legend Biotech Legend Biotech: AdCom Documents Shed Light On Carvykti's Problems (Downgrade) Legend Biotech Corporation (LEGN) Q4 2023 Earnings Call Transcript Legend Biotech Corporation 2023 Q4 - Results - Earnings Call Presentation ...
2024-04-17 15:00:04 ET Louise Chen from Johnson Rice issued a price target of $215.00 for JNJ on 2024-04-17 13:51:00. The adjusted price target was set to $215.00. At the time of the announcement, JNJ was trading at $144.32. The overall price target consensus is at $178....
2024-04-17 03:00:06 ET Summary Kenvue is a spinout from Johnson & Johnson, housing consumer health care brands like Tylenol and Benadryl. The spinout was driven by JNJ's desire to improve margins and growth by spinning off the consumer health care division. A mispricing of...
2024-04-16 18:22:06 ET More on Johnson & Johnson, Teva Pharmaceutical, etc. Johnson & Johnson (JNJ) Q1 2024 Earnings Call Transcript Johnson & Johnson 2024 Q1 - Results - Earnings Call Presentation Johnson & Johnson: Doubling Down On This 2024 Dog Of ...
2024-04-16 17:45:00 ET The latest earnings season has begun, and the latest quarterly results from some of our economy's largest companies are starting to come in. Tuesday morning, it was healthcare mainstay Johnson & Johnson 's (NYSE: JNJ) turn in the spotlight, and investo...
News, Short Squeeze, Breakout and More Instantly...
2024-04-18 11:00:03 ET Morten Herholdt from Johnson Rice issued a price target of $170.00 for JNJ on 2024-04-18 09:13:00. The adjusted price target was set to $170.00. At the time of the announcement, JNJ was trading at $145.08. The overall price target consensus is at $...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 73.2% to $0.0646 on volume of 191,555,690 shares AGBA Group Holding Limited (AGBA) rose 245.0% to $1.38 on volume of 41,065,125 shares TIAN RUIXIANG Holdings Ltd (TIRX) rose 135.2% to $1.14 on volum...
A look at the top 10 most actives in Canada Troilus Gold Corp (TLG) rose 1.4% to $0.7 on volume of 19,342,615 shares Royal Bank of Canada (RY) fell 0.1% to $133.2 on volume of 3,932,729 shares Desjardins RI Developed ex-USA ex-Canada - Low CO2 Index ETF (DRMD) rose 0.0% to $26.72 on volum...